Dıclehan Orhan - Concepedia

Author

Dıclehan Orhan

Also Known As

D Orhan, D. Orhan, DICLEHAN ORHAN, DUYGU DERSAN ORHAN, Dicle Orhan, Diclehan ORHAN, Diclehan Orhan, Doğa Orhan, DİCLEHAN ORHAN, Dıclehan Orhan

281

Publications

4.1K

Citations

H-Index

142

Concepts

All Affiliations

Hacettepe University Ankara University Hacettepe University Hospital Fondazione Ricerca Molinette

About

Dıclehan Orhan is an author at Hacettepe University specializing in medicine, pathology, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	51	2.1K
2	Public Health	2	2	153
3	Health Sciences	1	1	63
4	Allergy	1	1	18
5	Anesthesia	1	1	23

Dıclehan Orhan

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal-Recessive Osteogenesis Imperfecta Yasemin Alanay, Hrispima Avaygan, Natalia Camacho, The American Journal of Human Genetics SclerostinDevelopmental BiologyBone Morphogenic ProteinGeneticsOsteogenesis	2010	312
The MEST score provides earlier risk prediction in lgA nephropathy Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich, Kidney International Mest ScoreGlomerulonephritisMedicineKidney FailureLupus Nephritis	2015	279
Mutations in B3GALNT2 Cause Congenital Muscular Dystrophy and Hypoglycosylation of α-Dystroglycan Elizabeth Stevens, Keren Carss, Sebahattin Çirak, The American Journal of Human Genetics Mendelian DisorderDevelopmental BiologyGenetic DisorderMolecular BiologyDegenerative Disease	2013	192
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy Francesco Paolo Schena, Vito Walter Anelli, Joseph Trotta, Kidney International Glomerular DiseaseArtificial IntelligenceImmunoglobulin A NephropathyDiagnosisNephrology	2020	100
Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low‐ and high‐grade prostatic intraepithelial neoplasia and prostatic carcinoma Dıclehan Orhan, Çağatay Göğüş, Kadir Türkölmez, British Journal of Urology	2001	98
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort Rosanna Coppo, Danilo Lofaro, Roberta Camilla, Pediatric Nephrology Glomerular DiseaseGlomerulonephritisRenal DiseaseMedicineKidney Failure	2016	91
Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis Yiqin Zuo, Bong‐Kwon Chun, Sebastian A. Potthoff, Kidney International FibrosisUrologyRenal FunctionRenal PathologyRenal Inflammation	2013	88
INFLUENCE OF TUMOR STAGE, SIZE, GRADE, VASCULAR INVOLVEMENT, HISTOLOGICAL CELL TYPE AND HISTOLOGICAL PATTERN ON MULTIFOCALITY OF RENAL CELL CARCINOMA Sümer Baltacı, Dıclehan Orhan, Sedat Soyupek, The Journal of Urology	2000	72
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy Sean J. Barbour, Rosanna Coppo, Hong Zhang, Kidney International	2022	72
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort Shubha S. Bellur, S. A. Roberts, Stéphan Troyanov, Nephrology Dialysis Transplantation	2018	67

Page 1